Dr. Daniel Kim, MD

Claim this profile

Division of Cardiology, University of Alberta

Studies Cardiac Dysfunction
Studies Heart Transplant Rejection
3 reported clinical trials
5 drugs studied

Affiliated Hospitals

Image of trial facility.
Division Of Cardiology, University Of Alberta
Image of trial facility.
UMass Memorial Medical Center

Clinical Trials Daniel Kim, MD is currently running

Image of trial facility.

Vagus Nerve Stimulation

for Rheumatoid Arthritis

The RESET-RA study will assess the safety and efficacy of the SetPoint System (study device) for the treatment of adult patients with active, moderate to severe rheumatoid arthritis who have had an inadequate response or intolerance to biologic or targeted synthetic Disease-Modifying Anti-Rheumatic Drugs (DMARDs). The study device contains a miniaturized stimulator (implant) that is surgically placed under general anesthesia on the vagus nerve through a small incision on the left side of the neck (implant procedure). The study will enroll 250 subjects at 40 sites. All eligible subjects will undergo the implant procedure. Half of the subjects will receive active stimulation (treatment) and the other half will receive non-active stimulation (control). After completing primary endpoint assessments at Week 12, there will be a one-way crossover of control subjects to active stimulation and a 180-week open-label follow-up with all subjects (treatment and control) receiving active stimulation to evaluate long-term safety.
Recruiting1 award Phase 34 criteria

More about Daniel Kim, MD

Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Daniel Kim, MD has experience with
  • Molecular Microscope Diagnostic System
  • MMDx Diagnostic Test
  • HLA Antibody
  • Prospera
  • SetPoint System
Breakdown of trials Daniel Kim, MD has run
Cardiac Dysfunction
Heart Transplant Rejection
Arthritis
Rheumatoid Arthritis

Other Doctors you might be interested in

Aaron Remenschneider, MDUMass Memorial Medical Center
Majaz MoonisUMass Memorial Medical Center
Susan Zweizig, MDUMass Memorial Medical Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Kim, MD specialize in?
Daniel Kim, MD focuses on Cardiac Dysfunction and Heart Transplant Rejection. In particular, much of their work with Cardiac Dysfunction has involved treating patients, or patients who are undergoing treatment.
Is Daniel Kim, MD currently recruiting for clinical trials?
Yes, Daniel Kim, MD is currently recruiting for 1 clinical trial in Edmonton Alberta. If you're interested in participating, you should apply.
Are there any treatments that Daniel Kim, MD has studied deeply?
Yes, Daniel Kim, MD has studied treatments such as Molecular Microscope Diagnostic System, MMDx diagnostic test, HLA antibody.
What is the best way to schedule an appointment with Daniel Kim, MD?
Apply for one of the trials that Daniel Kim, MD is conducting.
What is the office address of Daniel Kim, MD?
The office of Daniel Kim, MD is located at: Division of Cardiology, University of Alberta, Edmonton, Alberta T6G 2R7 Canada. This is the address for their practice at the Division of Cardiology, University of Alberta.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top